Moderna Aces COVID-19 Vaccine Results With 94.5% Efficacy

Outperforms Pfizer At First Analysis

 
• By Andrew McConaghie
  
Moderna_Pills_Syringe
Moderna now looks set to join Pfizer/BioNTech in gaining emergency use authorization before the end of 2020.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip